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ABSTRACT  
Objective: To analyze the importance of Neonatal Screening for the treatment of children with phenylketonuria. 
Method: This is an integrative review. To select the studies we looked at the electronic databases Scientific Electronic 
Library Online - SciELO journal portal and CAPES in September 2013, using the keywords: Phenylketonuria, Triage, 
Child health. Results: The analysis of the articles indicated that in the period 2008-2013, the year 2010 had the highest 
number of publications. Most studies paused to examine the importance of neonatal screening program to evaluate the 
tracking phenylketonuria, as well as to characterize the performance of children diagnosed and treated early with 
phenylketonuria. Conclusion: Studies have shown that treatment is significantly more effective when deployed in pre - 
clinical stage of the disease and there is a screening test, the screening test, which is simple, efficient , applicable on 
a large scale and low cost. Descriptors: Phenylketonuria, Triage, Child health.
 
 
RESUMO 
Objetivo: Analisar a importância da Triagem Neonatal para o tratamento de crianças com fenilcetonúria. Método: 
Trata-se de uma revisão integrativa. Para selecionar os estudos, pesquisou-se nas bases de dados eletrônicas Scientific 
Eletronic Library Online – SCIELO e Portal de Periódicos da CAPES em setembro de 2013, utilizando os descritores: 
fenilcetonúria, triagem e saúde da criança. Resultados: A análise dos artigos indicou que no período de 2008 a 2013, o 
ano de 2010 teve o maior número de publicações. A maioria dos estudos deteve-se em analisar a importância da 
triagem neonatal, avaliar o programa para rastreamento de fenilcetonúria, assim como caracterizar o desempenho de 
crianças com fenilcetonúria diagnosticadas e tratadas precocemente. Conclusão: Os estudos mostraram que o 
tratamento é significativamente mais eficaz quando implantado na fase pré-clínica da doença e existe um teste de 
triagem, o teste do pezinho, que é simples, eficiente, aplicável em larga escala e de baixo custo. Descritores: 
Fenilcetonúria, Triagem e Saúde da criança. 
 
 
RESUMEN 
Objetivo: Analizar la importancia de Tamizaje Neonatal para el tratamiento de los niños con fenilcetonuria. Método: 
Se trata de una revisión integradora. Para seleccionar los estudios que analizamos las bases de datos electrónicas 
Scientific Electronic Library Online - Portal de la revista SciELO y CAPES en septiembre de 2013, utilizando las palabras 
clave: Fenilcetonuria, Triaje, Salud del Niño. Resultados: El análisis de los artículos se indica que en el período 2008-
2013, el año 2010 tuvo el mayor número de publicaciones. La mayoría de los estudios se detuvieron para examinar la 
importancia del programa de cribado neonatal para evaluar los fenilcetonuria seguimiento, así como para caracterizar 
el rendimiento de los niños son diagnosticados a tiempo con fenilcetonuria. Conclusión: Los estudios han demostrado 
que el tratamiento es significativamente más eficaz cuando se despliega en la etapa de pre - clínica de la enfermedad 
y hay una prueba de detección, la prueba de detección, que es simple, eficaz, aplicable a gran escala y bajo costo. 
Descriptores: Fenilcetonuria, Triaje, Salud del niño. 
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Phenylketonuria (PKU) is the most common 
of the inborn errors of amino acid metabolism. Due 
to a deficiency of phenylalanine hydroxylase, the 
enzyme that catalyzes the conversion of 
phenylalanine to tyrosine. The introduction of a 
diet low in phenylalanine should begin in the first 
months of life, preferably in the first month, to 
prevent mental retardation and more severe 
manifestation of the disease.¹ 
The hyperphenylalaninemia (HPA), the 
generic name given to high levels of phenylalanine 
(Phe) in blood, is a primary disorder of 
hydroxylating Phe system, which may be caused by 
a deficiency of the hepatic enzyme phenylalanine 
hydroxylase (PAH) or enzymes that synthesize or 
reduce the tetrahydrobiopterin coenzyme.² 
Phenylalanine is an essential aromatic 
amino acid, mainly metabolised in the liver. 
Phenylalanine which is not required for protein 
anabolism, tyrosine is hydroxylated by 
phenylalanine hydroxylase. This has a quaternary 
structure having four polypeptide chains, each 
connected to an iron atom, that binds oxygen, to 
form tyrosine.³ 
Different types of hyperphenylalaninemia 
can be found, according to the metabolic error 
involved, forming a heterogeneous group of 
diseases, including phenylketonuria (PKU) and 
classical variations of hyperphenylalaninemia 
(PAHs), as persistent HPA, the mild HPA and 
atypical PKU.4 
Currently in the healthcare scenario 
phenylketonuria has been diagnosed through 
neonatal screening tests, popularly known as the 
Guthrie Test, which is mandatory throughout the 
country since the 80s, after the implementation of 
the National Neonatal Screening Program (NNSP ). 
Thus, all newborns should undergo this test for 
screening of some metabolic abnormalities, 
including phenylketonuria, targeting the immediate 
initiation of treatment.5,6 
The phenylketonuric subjects are clinically 
normal at birth, beginning to manifest 
developmental delays around 6 months of age, 
with spasms, hypotonia, and rash. Display reduced 
pigmentation, microcephaly and epilepsy. The 
excretion of phenylketones provides the urine the 
characteristic odor.7 
However, it is known that Brazil is 
ethnically, socially and economically marked by 
numerous inequalities, making difficult the 
establishment and development of health 
programs, as an example of Neonatal Screening for 
the treatment of phenylketonuria. Thus, the 
success and effectiveness of neonatal screening 
programs depend mainly on the involvement of 
health authorities, educational campaigns including 
healthcare professionals and the population and 
investments. 
Given this issue the study aims to analyze 
the importance of Neonatal Screening for the 
treatment of children with phenylketonuria. 
 
 
 
 
 
This study is an integrative review. For its 
construction the following steps were covered: 
establishment of hypothesis and objectives of the 
integrative review, establishment of criteria for 
inclusion and exclusion of articles (sample 
selection); definition of information to be 
extracted from the selected articles, analysis of 
results, discussion and presentation the results and 
the last stage consisted of submitting the review.8 
INTRODUCTION 
 
 
 
 
 
 
 
 
METHODOLOGY 
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The guiding question for the construction of this 
integrative review was "What is the importance of 
Neonatal Screening for the treatment of 
phenylketonuria?". To select the references we 
looked at the electronic databases Scientific 
Electronic Library Online - SciELO and Periodical 
Portal CAPES in September 2013. 
In search for articles by standardized 
Descriptors in Health Sciences Headings (DECs) 
were to be used descriptors, which were: Child and 
neonatal phenylketonuria. 
After application of the descriptors the 
following results were found: in the database 
SCIELO sixty-six (26) Articles and Portal CAPES 
center and eighty (180) articles. The articles were 
subjected to cuts, which may be below Viewed in 
figure 1. 
 
Figure 1: search the banks of SCIELO and CAPES Portal Data 
Strategy. Teresina, 2013 
 
 
Following the electronic search, in order to 
identify items considered relevant and exclude 
those who did not meet the inclusion criteria, were 
selected survey regarding guiding question, full 
text, with humans (children), with reference to 
treatment of children with phenylketonuria and 
published since 2008. 
After identifying the related study material 
sorting the items, by reading the titles and 
abstracts was performed. Being excluded from jobs 
as editorials, thesis, dissertations, book reviews 
and interviews. After this step remained for the 
final sample of this review 14 articles. Studies that 
met the inclusion criteria were obtained in full. 
For the final analysis of the study an 
instrument that includes the following items was 
prepared: identifying the original article, 
methodological characteristics of the study, 
assessment of the methodological rigor of 
interventions measured and the results. In the next 
step, the data were subjected to critical analysis 
and further discussion and description of the 
results. 
 
  
 
 Frame 1 presents data on the articles 
analyzed for year, database, the publication title 
and magazines. The results indicated that 14 
articles were published in the period 2008-2013, 
with the year 2010 a large number of publications 
with four, followed by 2009 and 2012 with three 
two respectively. Have 2011 and 2013 had two 
publications each year. In reference to thematic of 
2008 showed up with smaller publication, 
highlighting just one article. 
 Regarding indexing of publications related 
to the theme was highlight the database SCIELO 
with nine published articles, followed by CAPES 
Portal with five. The more related to disclosures of 
research journal was the Brazilian Metabolic 
Endocrinology file with three articles and the rest 
were distributed in different journals that are 
synoptically highlighted in the table below. 
 
 
 
 
 
 
 
 
 
RESULTS AND DISCUSSION 
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Frame 1 - Details of the articles analyzed according to 
the database, year of publication, title of the article 
and periodicals of the publication. Teresina (PI), 2013. 
 
 
  
 Frame 2 is envisioned that the studies 
stopped to check the importance of screening of 
children diagnosed with PKU, the clinical and 
epidemiological characteristics, treatment, causes, 
demographic characteristics and clinical findings. 
Thus, the main objectives were related to: verify 
the importance of newborn screening for metabolic 
disorders and to evaluate the preventive and 
health promotion of children with phenylketonuria 
actions, analyze the causes, symptoms and dietary 
treatment of PKU infants; assess the national and 
international prevalence of phenylketonuria; 
characterize the performance, clinical and 
demographic characteristics of children with 
phenylketonuria. 
 
Frame 2 - Details of the articles analyzed in accordance 
with objectives of the studies. Teresina (PI), 2013. 
 
 In reference to the results of the studies 
can be inferred that the same reported various 
aspects of the importance of newborn screening, 
referring to the main consequences brought about 
by the condition and the effectiveness of the 
screening program to treat the disease, among 
other relations presented in frame 3. 
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Frame 3 - Details of articles analyzed according to the 
authors and the principal considerations identified in 
the studies. Teresina (PI), 2013. 
 
 After analysis it was realized that Brazil 
has a Newborn Screening Program that follows 
international guidelines, which appears to be 
irreversible, since it represents a considerable 
technical advance, being known worldwide as the 
largest public health program linked to genetics. 
But its consolidation is subject to certain medical 
and ethical issues that need to be discussed, 
because the progress of the program are new 
challenges as new issues and diseases are 
introduced into the diseases screened panel.9 
 But to the Newborn Screening Program 
can fully achieve its objectives, it is essential that 
some goals are met, as: collection of the blood 
sample obtained properly and in adequate time; 
fast referral of sample to the reference laboratory, 
conduct of examinations by laboratory obeying 
strict quality control, quick communication of test 
results; reference center endowed with doctor (s) 
trained (s) to establish (in) accurate diagnosis and 
structure for clinical follow-up of affected 
children; periodic evaluations of the quality 
program, reporting their results to the authorities, 
so that any improvements can be implemented. 10 
Thus, is emphatic to highlight that the process of 
newborn screening is not limited to collecting 
material for analysis, but is secondary to this, 
because without the dialogue with the other 
aforementioned steps, the program is limited and 
its proposal for early screening for the actual 
outcome / treatment and prevention of sequelae 
for child development become ineffective.¹¹ 
 Furthermore, within your functioning 
healthcare team involved has a role of great value, 
especially pediatricians and speech therapists 
occupy an important position in the treatment, the 
possible changes in referrals and improving the 
quality of life of these children, however data 
show that scientific knowledge pediatrician about 
the diseases screened, treatment and prognosis is 
still not concrete hampering the progress and 
establishment of some program issues, as well as 
effective treatment of children with 
phenylketonuria through diagnostic screening.9,12 
Nationwide access to newborn screening is very 
heterogeneous, for example, in 2007 in the state of 
Rio de Janeiro coverage reached 80.7%, unlike 
other cities. 13,14 
 Thus, states with less government 
involvement have a lower coverage, and those who 
have a position where the respective 
administrative bodies are more active, have 
greater coverage. Therefore, the involvement of 
health, government and local authorities and 
professional societies are critical milestones, not 
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only for the scope of coverage, but also with 
respect to the degree of opportunity of the 
collections.¹¹ 
 In this perspective it is important to 
emphasize that the Newborn Screening Program 
continually goes through reviews should meet the 
minimum requirements recommended by the 
Ministry of Health in the state of Tocantins, for 
example, the data indicate a significant evolution 
of the coverage rate, showing that the prevalence 
of diseases such as phenylketonuria and congenital 
hypothyroidism possessed lower rate than the 
national average, in turn, in Santa Catarina 
phenylketonuria was lower than the national 
prevalence, while the second condition was similar 
to global and national values.15,16 
 Also according to program evaluations 
collection of the first blood sample and initiation 
of treatment in many cases still occurs at a higher 
time than recommended by the Ministry of Health 
and delays that accumulate in various stages of the 
screening process can nullify the benefits of early 
detection, precept of a neonatal screening 
program. 14 Despite this evidence in literature 
suggests a positive perception of parents about the 
deployment, quality and evolution of the Newborn 
Screening Program, but there is controversy about 
the need for greater government support for such a 
program is optimized and can advance to the next 
stages.16 
 In this regard it is worth noting that the 
Newborn Screening Program is critical both for 
early screening of diseases that previously were 
not known, especially PKU, but mainly for the 
improvement and reduction in infant mortality 
from other diseases of genetic imprint. 
 But the early screening of diseases such 
as phenylketonuria achieved by the program does 
not guarantee a cure, as an example, it is 
important to highlight that individuals with 
phenylketonuria, even with early treatment, may 
show changes in cognitive functions, language, 
motor and social-behavioral. Thus scientific 
findings justify the referral of new proposals to the 
Ministry of Health with a view to hiring Speech 
Therapists in Newborn Screening Programs 
credentialed for full monitoring of individuals with 
this condition, ensuring less commitment and more 
effective treatment.17 
 Moreover, even with treatment and 
appropriate follow-up is still physiological changes 
caused primarily by dietary treatment, resulting 
from the disability and severe restriction on the 
consumption of foods containing the amino acid 
phenylalanine and secondary to this, other 
nutrients. This results in low intake of several 
nutrients, including selenium and calcium. Even 
with supplementation with formulas that seek to 
meet the needs of vitamins, minerals and essential 
amino acids, nutritional deficiencies are not 
discarded.18,19 
 However, scientific evidence showed that 
dietary treatment did not influence physiological 
changes in children with phenylketonuria, with an 
emphasis on auditory changes. Thus more studies 
showing the relationship of certain mixtures to 
recover possible deficiencies found and to ensure 
treatment and quality of life more suited to 
patients with phenylketonuria is needed.12 
 It is unquestionable that the Newborn 
Screening Program is extremely relevant for 
screening and early treatment of children 
diagnosed with PKU, however is noticeable through 
the scientific literature that changes accompanying 
the life cycle of these individuals, especially in the 
personal-social interaction, language and fine 
motor adaptive. In this sense, its long development 
is marked by changes that continually undermine 
your communication, social integration and 
learning.20 
 Thus the strengthening of the 
management of current health care to the 
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minimum requirements of the program in order to 
mimic the delay in diagnosis and increase the 
initiation of treatment for confirmed cases of 
diseases for diagnostic screening with special look 
is needed in this research for phenylketonuria, 
seeking to develop strategies to improve the 
operation, promoting a greater agility in the whole 
process and the start of treatment occurs in 
adequate time.21,22 
 
 
 
 
Studies have shown that treatment is 
significantly more effective when deployed in the 
preclinical phase of the disease, because of their 
minimum requirements and maintaining its 
efficiency applicable on a large scale and low cost. 
It is inferred after analysis that the 
Newborn Screening Program is extremely relevant 
for screening and early treatment of children 
diagnosed with PKU, but this does not guarantee a 
cure, since genetic diseases deserve further studies 
and even with proper treatment still there is the 
presence of many losses in lives of children with 
phenylketonuria, especially in personal-social, 
language and adaptive fine motor areas. Thus, it is 
hoped through this study a contribution to 
scientific production and fostering new research 
related to this theme. 
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